Structural Errors: Chromosomal Mutations Quiz

A chromosomal translocation occurs when a segment of one chromosome breaks off and reattaches to a non-homologous chromosome. Translocations can be reciprocal, where two chromosomes exchange segments, or non-reciprocal, where a segment moves from one chromosome to another without exchange. Translocations can disrupt gene function, alter gene expression, and are associated with various cancers and congenital disorders in humans.

In a reciprocal translocation, segments from two different non-homologous chromosomes are exchanged simultaneously. The total amount of genetic material is usually preserved, but the rearrangement can disrupt gene function at the breakpoints or alter the regulation of genes placed next to new chromosomal regions. Carriers of balanced reciprocal translocations may appear phenotypically normal but can have reproductive difficulties due to abnormal segregation during meiosis.

The Philadelphia chromosome results from a reciprocal translocation between chromosomes 9 and 22, written as t(9;22). This rearrangement fuses the BCR gene on chromosome 22 with the ABL1 gene on chromosome 9, creating the BCR-ABL1 fusion oncogene. The resulting protein is a constitutively active tyrosine kinase that drives uncontrolled cell proliferation, leading to chronic myelogenous leukemia. It is one of the most studied cancer-causing chromosomal translocations.

A chromosomal inversion occurs when a segment of a chromosome is cut out and reinserted in the opposite orientation. The total amount of DNA is preserved, but the gene order within the inverted segment is reversed. Inversions can disrupt genes at the breakpoints and alter gene expression patterns. They can also interfere with normal chromosome pairing during meiosis, potentially leading to chromosomal imbalances in offspring.

The two main types of chromosomal inversions are pericentric inversions, which include the centromere within the inverted segment, and paracentric inversions, which do not include the centromere. Reciprocal inversion and Robertsonian inversion are not standard classifications of chromosomal inversions. Robertsonian translocation is a distinct type of chromosomal rearrangement involving the fusion of two acrocentric chromosomes and is classified as a translocation, not an inversion.

A pericentric inversion spans the centromere, meaning the inverted segment includes the centromere. This can change the arm ratio of the chromosome if the breakpoints are asymmetrically placed on either side. In contrast, a paracentric inversion occurs entirely within one chromosomal arm and does not include the centromere. Both types can disrupt gene function at the breakpoints and cause problems during meiosis if a crossover occurs within the inverted region.

A Robertsonian translocation involves the joining of the long arms of two acrocentric chromosomes, typically chromosomes 13, 14, 15, 21, or 22, with the loss of their short arms. The carrier usually has 45 chromosomes but a near-normal amount of genetic material. Robertsonian translocations involving chromosome 21 are associated with an increased risk of Down syndrome in offspring, since the fused chromosome can segregate to produce unbalanced gametes.

Chromosomal inversions can change the spatial relationship between genes and their distant regulatory elements such as enhancers and silencers. Even if no gene is broken at the inversion breakpoints, a gene relocated to a new chromosomal neighborhood may come under the influence of inappropriate regulatory signals. This phenomenon, known as a position effect, can dramatically increase or decrease gene expression and has been linked to developmental disorders.

Balanced translocation carriers have no net gain or loss of genetic material because the chromosomal segments are exchanged rather than lost. As a result, most balanced translocation carriers are phenotypically normal and show no clinical symptoms. However, during meiosis, the rearranged chromosomes may segregate abnormally, producing unbalanced gametes. This can lead to miscarriage or offspring with chromosomal imbalances that do cause developmental or health problems.

An unbalanced chromosomal translocation results in a net gain or loss of genetic material because the exchanged segments are of unequal size or the translocation is non-reciprocal. This leads to partial monosomy or partial trisomy for the affected chromosomal regions. Unbalanced translocations are associated with developmental abnormalities, intellectual disability, and congenital malformations, depending on which genes are present in extra or reduced dosage.

Reciprocal translocations exchange segments between non-homologous chromosomes, and some translocations, like the BCR-ABL1 fusion, create oncogenic fusion genes. Robertsonian translocations can produce unbalanced gametes leading to aneuploidy in offspring. Balanced translocations do not usually cause developmental defects in the carrier themselves, as the total genetic content is preserved. These concepts underscore the importance of chromosomal structure in maintaining normal gene dosage and expression.

Fluorescence in situ hybridization and karyotyping are the standard clinical techniques for detecting chromosomal rearrangements such as translocations and inversions. Karyotyping provides a visual map of all chromosomes, allowing large rearrangements to be identified. Fluorescence in situ hybridization uses fluorescently labeled DNA probes to detect specific chromosomal sequences and confirm rearrangements at higher resolution. These tools are essential in cancer diagnosis and prenatal chromosomal analysis.

In inversion heterozygotes, the normal and inverted chromosomes must form an inversion loop during meiosis to allow proper pairing. If a crossover occurs within this loop, the resulting recombinant chromosomes are structurally abnormal and may carry duplications or deletions of genetic material. This can lead to embryonic lethality or offspring with developmental abnormalities, which is why inversion carriers often have reduced fertility or increased rates of pregnancy loss.

Chromosomal translocations are the most direct mechanism for creating fusion genes in cancer. When a translocation joins two previously separate chromosomal regions, the breakpoints can fuse two genes together, producing a hybrid protein with novel or dysregulated activity. The BCR-ABL1 fusion in leukemia and the EWS-FLI1 fusion in Ewing sarcoma are prominent examples. These fusion oncoproteins are important targets for molecularly targeted cancer therapies.

Chromosomal inversions reverse a DNA segment within the same chromosome without moving it to another chromosome, while translocations move segments between different chromosomes. Neither inversions nor translocations necessarily result in gene loss; balanced forms preserve the total genetic content. Paracentric inversions specifically do not include the centromere, distinguishing them from pericentric inversions. These differences are fundamental in chromosomal biology and clinical genetics.